All News about Biomarin Pharmaceuticals
![](/next-assets/images/schema-image-default.png)
What 5 Analyst Ratings Have To Say About Biomarin Pharmaceutical
January 30, 2023
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2019/07/drug_stocks1600.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/01/12/stock-exchange-g894ab76ae_1920.jpg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2016/06/ibd.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/01/11/bmrn.png?width=1200&height=800&fit=crop)
6 Analysts Have This to Say About Biomarin Pharmaceutical
January 11, 2023
Via Benzinga
![](https://g.foolcdn.com/editorial/images/715748/gettyimages-471674455.jpg)
Expert Ratings for Biomarin Pharmaceutical
November 29, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_6675.png?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/706594/scientist-looking-through-microscope-1.jpg)
![](https://images.pexels.com/photos/2280549/pexels-photo-2280549.jpeg?auto=compress&cs=tinysrgb&h=750&w=1260)
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 01, 2022
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-federal-hall.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/options_image_2560.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_28096.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/13/aapharma_0.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/10/07/aapharma_2.png?width=1200&height=800&fit=crop)
BioMarin Lays Off 4% Of Its Workforce To 'Simplify' The Company
October 07, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/11/23/bmrn.png?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2017/12/Stock-biotech-12-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/11/23/thermometer-1539191.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/03/image_2.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_28905.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/31/image-mastercard.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_28900.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For October 31, 2022
October 31, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_8987.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_1441.png?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2017/12/Stock-biotech-12-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/09/12/aapharma_18.png?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2020/01/A1MAIN-biotech-011020-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/08/24/bz-pharma_4.jpg?width=1200&height=800&fit=crop)
Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary
August 24, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.